BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17401395)

  • 1. Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation.
    Hakki M; Limaye AP; Kim HW; Kirby KA; Corey L; Boeckh M
    Bone Marrow Transplant; 2007 Jun; 39(11):687-93. PubMed ID: 17401395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?
    Chen SC; Lawrence RH; Byth K; Sorrell TC
    Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.
    Kang CI; Kim SH; Kim HB; Park SW; Choe YJ; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2003 Sep; 37(6):745-51. PubMed ID: 12955633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia.
    Cheong HS; Kang CI; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
    Am J Med; 2008 Aug; 121(8):709-14. PubMed ID: 18691485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Respiratory infection caused by Pseudomonas aeruginosa in patients with HIV infection].
    Arrizabalaga Aguirreazaldegui J; Horcajada Gallego JP; Mentxaka Ugalde B; Rodríguez Arrondo F; Iribarren Loyarte JA; von Wichman de Miguel M; Garde Orbaiz C
    Rev Clin Esp; 1996 Oct; 196(10):678-83. PubMed ID: 9005470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
    Johnson LE; D'Agata EM; Paterson DL; Clarke L; Qureshi ZA; Potoski BA; Peleg AY
    Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.
    Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA
    Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa infection after living-donor liver transplantation in adults.
    Hashimoto M; Sugawara Y; Tamura S; Kaneko J; Matsui Y; Kokudo N; Makuuchi M
    Transpl Infect Dis; 2009 Feb; 11(1):11-9. PubMed ID: 18811632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Clin Microbiol Infect; 2005 May; 11(5):415-8. PubMed ID: 15819873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.
    Pressler T; Frederiksen B; Skov M; Garred P; Koch C; Høiby N
    J Cyst Fibros; 2006 Jan; 5(1):9-15. PubMed ID: 16412706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.
    Lodise TP; Patel N; Kwa A; Graves J; Furuno JP; Graffunder E; Lomaestro B; McGregor JC
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3510-5. PubMed ID: 17646415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation.
    Nesher L; Rolston KV; Shah DP; Tarrand JT; Mulanovich V; Ariza-Heredia EJ; Chemaly RF
    Transpl Infect Dis; 2015 Feb; 17(1):33-8. PubMed ID: 25546740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide study of invasive Pseudomonas aeruginosa infection in Norway: importance of underlying disease.
    Iversen BG; Brantsaeter AB; Aavitsland P
    J Infect; 2008 Aug; 57(2):139-46. PubMed ID: 18617269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection.
    Suárez C; Peña C; Gavaldà L; Tubau F; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e73-8. PubMed ID: 20223693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of Pseudomonas aeruginosa colonizations/infections in lung transplant recipients.
    Zeglen S; Wojarski J; Wozniak-Grygiel E; Siola M; Jastrzebski D; Kucewicz-Czech E; Zembala M
    Transplant Proc; 2009 Oct; 41(8):3222-4. PubMed ID: 19857715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation in patients with active fungal infection: not a contraindication for transplantation.
    Aki ZS; Sucak GT; Yeğin ZA; Güzel O; Erbaş G; Senol E
    Transplant Proc; 2008 Jun; 40(5):1579-85. PubMed ID: 18589155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.